4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-21-001536
CIK 0001583107other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:43 PM ET
Size
4.7 KB
Accession
0001179110-21-001536
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Award
Ordinary Shares
2021-02-08+65,000→ 188,688 total
Footnotes (1)
- [F1]Includes 553 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 13, 2020.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:43 PM ET
- Size
- 4.7 KB